Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 4/20 | 0.51 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.50 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.50 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.50 |
| ▸ | ALPI | P09923 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | XIAP | P98170 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | TPH1 | P17752 | 3/20 | 0.44 |
| ▸ | GRB2 | P62993 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | LCK | P06239 | 1/20 | 0.44 |
| ▸ | FYN | P06241 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22645606 | 0.91 | SLC7A5 (0.61) | SLC7A5PTPN1PTGS1ITGB3ITGA2B | |
| SCHEMBL671002 | 0.91 | SLC7A5 (0.61) | SLC7A5PTPN1PTGS1ITGB3ITGA2B | |
| SCHEMBL450849 | 0.91 | SLC7A5 (0.61) | SLC7A5PTPN1PTGS1ITGB3ITGA2B | |
| SCHEMBL4581449 | 0.84 | SLC7A5 (0.56) | SLC7A5PTPN1PTGS1ITGB3ITGA2B | |
| SCHEMBL684389 | 0.83 | ITGB3 (0.46) | ITGB3ITGA2BKMT2APOLBPPARG | |
| SCHEMBL12053134 | 0.83 | ITGB3 (0.46) | ITGB3ITGA2BKMT2APOLBPPARG | |
| SCHEMBL451772 | 0.83 | SLC7A5 (0.62) | SLC7A5PTPN1PTGS1ITGB3ITGA2B | |
| SCHEMBL2336902 | 0.82 | OPRK1 (0.44) | SLC7A5PTPN1ITGB3ITGA2BKMT2A | |
| SCHEMBL4629444 | 0.81 | SLC7A5 (0.56) | SLC7A5PTPN1PTGS1ITGB3ITGA2B | |
| SCHEMBL9937712 | 0.81 | SLC7A5 (0.56) | SLC7A5PTPN1PTGS1ITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110312890-A1 | ACETYLATED AMINO ACIDS AS ANTI-PLATELET AGENTS, NUTRITIONAL AND VITAMIN SUPPLEMENTS | SIGNATURE R&D HOLDINGS, LLC (US) | 2011-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110312890-A1 | ACETYLATED AMINO ACIDS AS ANTI-PLATELET AGENTS, NUTRITIONAL AND VITAMIN SUPPLEMENTS | PLTP, GP6, PDGFA | SLC7A5 500/4885PTPN1 4264/4885PTGS1 190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.